On July 7, Innovent Biologics fell 3.04% in regular trading, trading at HKD 87.9/share, with turnover of HKD 696 million.
Within the Biotechnology sector where Innovent Biologics belongs, the sector faced broad selling pressure. Among individual stocks, REMEGEN down 5.29%, AKESO down 3.14%, BEIGENE down 1.89%, SKB BIO down 1.62%, KEYMED BIO-B down 1.44%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)